In animal studies, Epithalon has been shown to: Increase average and maximum lifespan Reduce chromosomal aberrations Delay the onset of age-related diseases Improve neuroendocrine function and melatonin secretion Regulate gene expression related to longevity Perhaps most notably, Epithalon has been found to reactivate telomerase , an enzyme that rebuilds telomeres and potentially resets the cellular aging clock
Am J Resp Critical Care Medicine, 2017
According to a 2014 review published in The Lancet: Diabetes & Endocrinology, titled Sarcopenia: A Fate Worth Challenging , loss of muscle mass and strength is an important risk factor for accelerating rates of physical disability, hospitalization, and death in the older population
The review concluded that glutathione carries anti-melanogenic and antioxidant properties that support its use in treating hyperpigmentation and melasma
Week one: initial adjustment The first week often involves minimal visible change
The answer depends on the compound and the research application: For systemic effects (body composition, hormonal, neurological) subcutaneous injection is the established research standard [17] For localised GI research (gut healing, IBD models) oral BPC-157 has specific relevance and is supported by animal studies [8] [9] For cognitive/neurological research intranasal delivery has been studied for Semax and Selank, but injectable remains the more common research route [13] [12] When in doubt, the published research literature almost always specifies the delivery method used